title: Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer.
abstract: Among the hypotheses discussing cancer formation, the cancer stem cell (CSC) theory is one receiving widespread support. One version of this theory states that changes in otherwise healthy cells can cause formation of tumor- initiating cells (TICs), which have the potential to create precancerous stem cells that can lead to CSC formation. These CSCs can be rare, in contrast to their differentiated progeny, which give rise to the vast majority of the tumor mass in most cancers. Loss of imprinting (LOI) of the insulin-like growth factor-2 (IGF2) gene is one change that can produce these TICs via an epigenetic progenitor model of tumorigenesis. While IGF2 usually supports normal cellular growth, LOI of IGF2 may lead to overexpression of the gene and moreover global chromatin instability. This modification has been observed in many forms of cancer, and given the effect of LOI of IGF2 and its role in cancer, detecting a loss of imprinting in this gene could serve as a valuable diagnostic tool. Preclinical data has shown some progress in identifying therapeutic approaches seeking to exploit this relationship. Thus, further research surrounding LOI of IGF2 could lead to increased understanding of several cancer types and enhance therapies against these diseases.
authors.affiliation: Georgetown University School of Medicine, Georgetown University Washington DC, USA.
authors.forename: Mark B
authors.initials: MB
authors.lastname: Leick
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Shoff
authors.forename: Erwin C
authors.initials: EC
authors.lastname: Wang
authors.forename: Jaclyn L
authors.initials: JL
authors.lastname: Congress
authors.forename: G Ian
authors.initials: GI
authors.lastname: Gallicano
keywords: Insulin like growth factor 2 (IGF2); cancer stem cell; epigenetic; loss of imprinting; progenitor